Economic analysis based on multinational studies: Methods for adapting findings to national contexts

Journal of Public Health

Volumn 18, Issue 4, 2010, Pages 327-335

  Reinhold, Thomas ^a   Brüggenjürgen, Bernd ^a   Schlander, Michael ^b   Rosenfeld, Stephanie ^c   Hessel, Franz ^c,d   Willich, Stefan N ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Hochschule Ludwigshafen am Rhein   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cost effectiveness; Economic evaluation; International adaption; Transferability

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DATA BASE; DECISION MAKING; DEMOGRAPHY; EVALUATION; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; REVIEW; STATISTICAL ANALYSIS; TECHNIQUE;

EID: 77954955182     PISSN: 09431853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10389-010-0315-0     Document Type: Review

References (31)

1. Asplund K, Ashburner S, Cargill K, Hux M, Lees K, Drummond M, et al (2003) Health care resource use and stroke outcome. Multinational comparisons within the GAIN International trial. Int J Technol Assess Health Care 19(2):267-277
2. Bastian H, Bender R, Ernst AS, Kaiser T, Kirchner H, Kolominsky-Rabas P, Lange S, Sawicki PT, Weber M (2006) Methoden. Köln: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). Report No.: version 2.0
3. Bryan S, Brown J (1998) Extrapolation of cost-effectiveness information to local settings. J Health Serv Res Policy 3(2):108-112
4. Bytzer P (1999) Cost-effectiveness of gastroscopy. Ital J Gastroenterol Hepatol 31(8):749-760
5. Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J, O'Hagan T (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 14(4):339-347
6. Cook JR, Drummond M, Glick H, Heyse JF (2003) Assessing the appropriateness of combining economic data from multinational clinical trials. Stat Med 22(12):1955-1976
7. Demol P, Weihrauch TR (1997) Multi-national clinical therapy studies. Design, management and costs (in German). Med Klin (Munich) 92(2):117-123
8. Drummond MF, Pang F (2001) Transferability of economic evaluation results. In: Drummond MF, McGuire A (eds) Economic evaluation in health care: merging theory with practice. Oxford University Press, Oxford
9. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW (1997) Methods for economic evaluation of health care programmes, 2nd edn. Oxford University Press, Oxford
10. Grieve R, Nixon R, Thompson SG, Normand C (2005) Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ 14(2):185-196
11. Halliday RG, Darba J (2003) Cost data assessment in multinational economic evaluations: some theory and review of published studies. Appl Health Econ Health Policy 2(3):149-155
12. Hay J, Jackson J (1999) Panel 2: methodological issues in conducting pharmacoeconomic evaluations-modeling studies. Value Health 2(2):78-81
13. Heyland DK, Kernerman P, Gafni A, Cook DJ (1996) Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit? Crit Care Med 24(9):1591-1598
14. Hjelmgren J, Berggren F, Andersson F (2001) Health economic guidelines-similarities, differences and some implications. Value Health 4(3):225-250
15. Jönsson B, Weinstein MC (1997) Economic evaluation alongside multinational clinical trials. Study considerations for GUSTO IIb. Int J Technol Assess Health Care 13(1):49-58
16. Kaplan GA, Keil JE (1993) Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 88(4 Pt 1):1973-1998
17. Koopmanschap MA, Touw KC, Rutten FF (2001) Analysis of costs and cost-effectiveness in multinational trials. Health Policy 58 (2):175-186
18. Manca A, Willan AR (2006) 'Lost in translation': accounting for between-country differences in the analysis of multinational costeffectiveness data. Pharmacoeconomics 24(11):1101-1119
19. Menzin J, Oster G, Davies L, Drummond MF, Greiner W, Lucioni C, Merot JL, Rossi F, vd Schulenburg JG, Souêtre E (1996) A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis. Int J Technol Assess Health Care 12 (1):52-61
20. Moayyedi P (2007) The health economics of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21(2):347-361
21. O'Brien BJ (1997) A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. Am J Manag Care 3 (Suppl):S33-S39
22. Ontario Ministry of Health and Long-Term Care (1994) Ontario guidelines for economic analysis of pharmaceutical products. Queen's Printer for Ontario
23. Pang F (2002) Design, analysis and presentation ofmultinational economic studies: the need for guidance. Pharmacoeconomics 20(2):75-90
24. Pinto EM, Willan AR, O'Brien BJ (2005) Cost-effectiveness analysis for multinational clinical trials. Stat Med 24(13):1965-1982
25. Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA et al (2005) Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 149 (3):434-443
26. Schöffski O, Graf von der Schulenburg JM (2007) Die Standardisierung der Methodik: Guidelines. In: Gesundheitsökonomische Evaluationen, 3 ed. Spinger, Berlin, pp 471-489
27. Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davis LM, Eastwood A (2004) Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 8(49):iii-iv
28. Siebert U (2003) When should decision-analytic modeling be used in the economic evaluation of health care? Eur J Health Econ 4:143-150
29. Thompson SG, Nixon RM, Grieve R (2006) Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. J Health Econ 25(6):1015-1028
30. Willan AR, Pinto EM, O'Brien BJ, Kaul P, Goeree R, Lynd L, Armstrong PW (2005) Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Econ 14(4):327-338
31. Willke RJ, Glick HA, Polsky D, Schulman K (1998) Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ 7(6):481-493